Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Biologics - Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
Mylan Inc. - Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately
Pneumonia - Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA New Data on Ceftaroline, a Novel, Broad-Spectrum Ceph
Rochon Genova - Significant increased risk of heart attack and stroke triggers Zelnorm national class
Sidley Austin LLP - Sidley Austin LLP Adds Senior Life Sciences Lawyer in Shanghai Office
Ulcerative Colitis - APRISOTM Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Abdominal Aortic Aneurysm - Data on abdominal aortic aneurysm published by researchers at Karolinska University
Adverse Drug Reactions - Dermipsor Reports Positive Phase 2b Results Showing Efficacy and Synergy of its Leading Product DPS-101, a Non- Steroidal Combination Drug to Treat Psoriasis the data showed statistical significant efficacy in most arms.
Akorn, Inc. - Akorn, Inc. Announces FDA Approval of Adenosine Injection USP, 3 mg/mL
Alexza Pharmaceuticals, Inc. - Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
Aneurysm - Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval
Angiogenesis - Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models
Anthrax - Studies from University of Cincinnati reveal new findings on anthrax
Antigenics Inc. - Antigenics Reports Third Quarter 2008 Financial Results
ARYx Therapeutics Inc. - ARYx Therapeutics Inc. Completes Enrollment in EmbraceAC Study -- Phase 2/3 Clinical Trial Comparing Anticoagulant ATI-5923 Against Warfarin
Asthma - Pivotal Data Showed Symbicort® Improved Lung Function In Adults With Copd
Cardiology - LifeNet Health Receives FDA Clearance for New Cardiovascular Technology
Case Western Reserve University - Case Western Reserve University professors call for regulation of electronic health records
Cell Therapeutics, Inc. - Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
Cepheid - Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
Clinical Trial Research - Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial
Clinical Trial Research - PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
Colon Cancer Risk Factors - Research from University of Cambridge, Institute of Public Health has provided new data on colon cancer risk factors
Contraception - Reports outline contraception research from University of Florida
Hantavirus - New findings from University of Basel describe advances in hantavirus
Hepatitis C Virus Prevention - Reports outline hepatitis C virus prevention study findings from Institute of Public Health
Herpetic Keratitis - Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
Inhalation Solution - Mylan's Dey L.P. Announces Establishment of 'J-Code' for Perforomist(TM) Inhalation Solution
Lawson Software - Lawson Software and Dubai-Based E3 Participate in Middle East Healthcare Event
Life Sciences - Investigators at Johns Hopkins University target life sciences
Life Sciences - Investigators at Medical University of Innsbruck, Department of Pediatrics publish new data on pediatric in children
Life Sciences - Research reports on life sciences from J.F. Guest and colleagues provide new insights
Life Sciences - Researchers from University of East Anglia describe findings in life sciences
Life Sciences - Study findings on life sciences are outlined in reports from A. Valenciamendoza and colleagues
Macular Degeneration - Long-Term Results of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Published in the American Journal of Ophthalmology
Mass Spectrometry - Studies from M. Breda and colleagues provide new data on mass spectrometry
Melanoma - Studies from University of Liverpool in the area of melanoma published
MIT Holding, Inc. - MIT Holding, Inc. Chief Science Advisor Assists the Republican and Democratic National Conventions
Non-Hodgkin Lymphoma - Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Nucryst Pharmaceuticals Corp. - New Acticoat Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada
Obesity - New obesity findings from University of Pittsburgh, Western Psychiatric Institute published
Osteoarthritis - NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
Paramyxovirus - Data on paramyxovirus described by researchers at Department of Agriculture
Pathology - New pathology research from B. Iulini and co-researchers described
Pediatrics - FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
Pfizer Inc - Pfizer's TOVIAZ fesoterodine fumarate Receives FDA Approval for the Treatment of Overactive Bladder
Premenstrual Dysphoric Disorders Therapy - Scientists at University of California, Center for Health Sciences release new data on premenstrual dysphoric disorders therapy
Regulatory Actions - Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
Regulatory Actions - SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R)
Regulatory Actions - Studies from M.C. Gaudiano et al further understanding of regulatory actions